BNP/CALL/STRYKER CORP./300/0.1/20.12.24 Share Price

Warrant

DE000PN38H21

Delayed Deutsche Boerse AG 11:50:36 28/06/2024 BST
5.02 EUR +0.20% Intraday chart for BNP/CALL/STRYKER CORP./300/0.1/20.12.24
Current month+0.20%
1 month+2.87%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
28/06/24 5.02 +0.20%
27/06/24 5.01 -0.40%
26/06/24 5.03 +4.14%
25/06/24 4.83 -2.62%
24/06/24 4.96 -4.62%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 11:50 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN38H2
ISINDE000PN38H21
Date issued 02/06/2023
Strike 300 $
Maturity 20/12/2024 (176 Days)
Parity 10 : 1
Emission price 2.93
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 7.25
Lowest since issue 1.77
Delta0.8x
Omega 5.048
Premium4.02x
Gearing6.28x
Moneyness 1.135
Difference Strike -40.54 $
Difference Strike %-13.51%
Spread 0.05
Spread %0.98%
Intrinsic value 3.786

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
340.5 USD
Average target price
372.9 USD
Spread / Average Target
+9.51%
Consensus